The new Digital India Act and Data Protection Act 2023 raise crucial questions about privacy, consent, and government access. Here's what every Indian needs to know about their digital rights now.
Tarn Taran police intensify the war on drugs with Phase 2. SSP Ranjit Singh leads a major crackdown, seizing assets and arresting peddlers. Read the full strategy.
In a NYT interview, Donald Trump revealed he hasn't used GLP-1 drugs like Ozempic, sparking debate on obesity, healthcare costs, and his administration's drug price policies. Read the full story.
GLP-1 weight-loss drugs, despite limited uptake, topped India's pharma sales by value in 2025. With generics and new approvals coming, 2026 promises wider access. Plus, government plans 200+ Day Care Cancer Centres. Read the full analysis.
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Karnataka's Pre-University Board expands digital exam facility to II PU students from 2024-25, offering a choice between pen-paper and online tests. Learn about the new initiative.
A Bengaluru software engineer was arrested for allegedly manufacturing synthetic drugs like MDMA in a makeshift home laboratory. Police seized drugs worth lakhs and equipment. Read the shocking details.
Drugs Control Administration officials raided an unlicensed clinic in Karimnagar, seizing illegal steroids and antibiotics. The crackdown highlights the public health risks of unauthorized drug sales. Read more.
Explore why nations like Bulgaria, Spain & Japan are launching digital nomad visas to attract remote professionals. Learn how this trend benefits economies and what it means for India's 1.9 million digital nomads.
Explore the social and economic impact of GLP-1 drugs like Ozempic & Mounjaro in India. A ₹1,000 crore market is poised for massive growth. Share your thoughts.
New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.
A severe shortage of drug inspectors is hampering enforcement against spurious and adulterated medicines in India. Officials admit the staffing crisis is a major hurdle. Read more on the critical public health issue.
Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.
The Supreme Court has agreed to hear SAD leader Bikram Singh Majithia's plea for bail in a drugs case. The hearing is scheduled for July 15. Read the latest legal developments.
Karnataka Assembly passes the Drugs and Cosmetics (Amendment) Bill, 2024, enhancing penalties for spurious drug manufacturers and regulating online pharmacy sales. Learn the key changes.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi's Drugs Control department sealed a shop & collected 204 samples from 27 wholesale dealers in a major drive against illegal drug trade. Health Minister vows zero tolerance for spurious medicines.
India's digital economy is expanding at 2.6 times its GDP, driving Asia-Pacific's transformation. Discover the key drivers and future projections shaping this rapid growth.
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Massive drug bust in Mizoram: Narcotics worth Rs 479 crore seized, including meth tablets and heroin. Four suspects arrested in major anti-narcotics operation. Read details.
Mumbai Police ANC summons Siddhant Kapoor, brother of Shraddha Kapoor, and influencer Orry in connection with the massive ₹252 crore MD drug seizure case. Read latest updates.
Germany's justice ministry reclassifies date rape drugs as weapons in criminal trials, strengthening prosecution of sexual assault cases. Learn how this legal change protects victims.
Osstem Implant leads India's dental transformation with K-Digital Dentistry, enhancing precision and accessibility. Discover how digital innovation is reshaping dental care.
Indian government proposes sweeping ban on online advertisements for Schedule G, H, H1, and X drugs to combat self-medication and antimicrobial resistance. Read about the new regulatory changes.
Apple introduces Digital ID feature allowing iPhone users to store passport information in Apple Wallet for TSA checkpoints across 250+ US airports. Learn how it works and limitations.
Mumbai Police summons socialite Orry in Rs 252 crore drug case. He seeks new date citing prior commitments. Investigation continues in high-profile narcotics bust.
As global protectionism rises, India's homegrown digital infrastructure like UPI and Aadhaar provides crucial sovereignty. Learn how these systems protect our digital future.
Social media influencer Orry faces Mumbai Police questioning in massive Rs 252 crore mephedrone drug bust case uncovered in Sangli. Latest developments.
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.